With cardiovascular disease recognized as the leading cause of death worldwide in both genders, the significance of lipid disorders as a primary risk factor cannot be ignored. Building on the successful first volume in the series, The Year in Dyslipidaemia 2003 reviews nearly 200 recently published papers from 45 different journals, covering the entire range of lipid disorders and their diagnosis and treatment. A panel of experts review the latest clinical trials, the articles update coverage found in the previous volume. New chapters include topics such as "Disorders which cause hypolipidaemia" and "Gender and coronary heart disease." This single-volume overview of current peer-reviewed literature keeps busy clinicians up to date and helps them identify more effective strategies for patient care.